Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Caesarean delivery: conflicting interests.
Osuna E, Pérez Cárceles MD, Sánchez Ferrer ML, Machado F. Osuna E, et al. Among authors: machado f. Reprod Biomed Online. 2015 Dec;31(6):815-8. doi: 10.1016/j.rbmo.2015.08.007. Epub 2015 Aug 14. Reprod Biomed Online. 2015. PMID: 26371711
Ovarian cancer during pregnancy: analysis of 15 cases.
Machado F, Vegas C, Leon J, Perez A, Sanchez R, Parrilla JJ, Abad L. Machado F, et al. Gynecol Oncol. 2007 May;105(2):446-50. doi: 10.1016/j.ygyno.2007.01.002. Epub 2007 Feb 9. Gynecol Oncol. 2007. PMID: 17292456
P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.
Barberà-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Pelegrín P. Barberà-Cremades M, et al. Among authors: machado f. FASEB J. 2012 Jul;26(7):2951-62. doi: 10.1096/fj.12-205765. Epub 2012 Apr 6. FASEB J. 2012. PMID: 22490780
Therefore, P2X7R antagonists emerge as novel therapeutics for the treatment for acute inflammation, pain and fever, with wider anti-inflammatory activity than currently used cyclooxygenase inhibitors.-Barbera-Cremades, M., Baroja-Mazo, A., Gomez, A. I., Machado, F., …
Therefore, P2X7R antagonists emerge as novel therapeutics for the treatment for acute inflammation, pain and fever, with wider anti-inflamma …
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial.
de Barros E Silva PGM, Furtado RHM, de Alcântara Chaud MS, Macedo AVS, Bronhara B, Damiani LP, Barbosa LM, Suiama MA, Ramacciotti E, de Aquino Martins P, de Oliveira AL, Nunes VS, Ritt LEF, Rocha AT, Tramujas L, Santos SV, Diaz DRA, Viana LS, Melro LMG, Figueiredo EL, Neuenschwander FC, Dracoulakis MDA, Lima RGSD, de Souza Dantas VC, Fernandes ACS, Gebara OCE, Hernandes ME, Queiroz DAR, Veiga VC, Canesin MF, de Faria LM, Feitosa-Filho GS, Gazzana MB, Liporace IL, de Oliveira Twardowsky A, Maia LN, Machado FR, de Matos Soeiro A, Conceição-Souza GE, Armaganijan L, Guimarães PO, Rosa RG, Azevedo LCP, Alexander JH, Avezum A, Berwanger O, Cavalcanti AB, Lopes RD; ACTION Coalition COVID-19 Brazil IV Investigators. de Barros E Silva PGM, et al. Among authors: machado fr. J Thromb Thrombolysis. 2024 May 18. doi: 10.1007/s11239-024-02995-y. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 38762708
1,174 results